SHPH.NASDAQ
- Shuttle Pharmaceuticals Holdings Inc
(財政狀態)
報價延遲最少15分鐘:2025/05/10 04:39 EDT
|
|
|
|
|
||||||||||||
|
|
|
|
|
0.2325 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-3.30/--
|
|
企業價值
1.93M
|
| 資產負債 |
|
每股賬面淨值
0.11
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
0
|
|
每股收益
--
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/05/10 04:39 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Shuttle Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company leveraging its proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments with surgery, radiation therapy, chemotherapy and immunotherapy. Radiation therapy (RT) is one of the effective modalities for treating cancers. It is developing a pipeline of products designed to address the limitations of the current cancertherapies as well as to extend to the new applications of RT. The company believes that its product candidates will enable the company to deliver cancer treatments that are safer, more reliable and at a greater scale than that of the current standard of care. |